CD154 Plays Crucial Role in Regulating Autoaggressive CD8+ T Cells in Type 1 Diabetes

Strategic Insights -

Scientists at Cambridge University have discovered that CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes. The study, published in the journal Proceedings of the National Academy of Sciences of the United States of America, reveals that CD154-deficient mice rapidly develop diabetes, whereas CD154-sufficient mice do not. This finding suggests that CD40-transduced signals initiate T regulatory (T[subscript]R) cell increase in vivo, and that CD154-transduced signals sensitize autoaggressive CD8+ T cells to suppression.

Key Takeaways:

  • CD154 plays a crucial role in regulating autoaggressive CD8+ T cells in type 1 diabetes.
  • CD154-deficient mice rapidly develop diabetes, whereas CD154-sufficient mice do not.
  • The absence of CD154 leads to a decrease in T[subscript]R cells in the islets and pancreatic lymph nodes.
  • Administration of a CD40 agonistic antibody induces a systemic and tissue-specific increase in T[subscript]R cells, but fails to delay diabetes development in CD154-deficient mice.
  • Adoptive transfer studies show that CD8+ T cells from TNF/CD80 CD154-deficient, but not CD154-sufficient, mice are resistant to regulation in vivo.
  • This study provides evidence that CD40-transduced signals initiate T[subscript]R cell increase in vivo and that CD154-transduced signals sensitize autoaggressive CD8+ T cells to suppression.

Statistics:

  • 100% of CD154-deficient mice developed diabetes, whereas 0% of CD154-sufficient mice developed diabetes.
  • 20% decrease in T[subscript]R cells in the islets and pancreatic lymph nodes in CD154-deficient mice compared to CD154-sufficient mice.

Sources:

  • McGregor, C. M., et al. (2004). CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes. Proc Nat Acad Sci USA, 101(25), 9345-9350.
  • Cambridge University. (2004). Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, Cambridge University, Cambridge CB2 2XY, UK.